Sputnik V Becomes 3rd COVID-19 Vaccine To Launch In India


Russia’s Sputnik V becomes 3rd COVID-19 Vaccine to launch in India after Covishield and Covaxine.

However, Sputnik V has an efficiency of over 91%.

This means it has the ability to stop the risk by 91% from COVID-19 for the people who have been taking this Vaccine.

It is also a 2 dose vaccine just like Covishield and Covaxine.

Dr Reddy’s Laboratories are doing a production of Sputnik V Vaccine in India.

They are looking to manufacture around 15cr doses by the end of this year in India.

The production in India will starts in July.

Gamaleya Research Institute of Epidemiology and Microbiology based in Moscow has made this vaccine.

The first dose of this vaccine has been administered in Hyderabad.

But, This Vaccine will be priced at Rs. 995 rs in India per dose.

The price will go down after it will start manufacturing in India.

This Russian Vaccine will start available in the market next week.



Please enter your comment!
Please enter your name here